Histone Lactylation-Driven GPD2 Mediates M2 Macrophage Polarization to Promote Malignant Transformation of Cervical Cancer Progression
DNA and Cell Biology · 01.12.2024 · 43 (12) · 605-618
DOI: 10.1089/dna.2024.0122 ↗Kurz gefasst
Fachartikel in der Zeitschrift DNA and Cell Biology, erschienen am 01.12.2024. Verfasst von Chenlingzi Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the First Affiliated Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Histones, Macrophages, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, the First Affiliated Hospital of Jinan University, Guangzhou, China.
- Department of Obstetrics and Gynecology, the Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Chenlingzi Huang
Zitieren
APA
Huang, C., Xue, L., Lin, X., Shen, Y., & Wang, X. (2024). Histone Lactylation-Driven GPD2 Mediates M2 Macrophage Polarization to Promote Malignant Transformation of Cervical Cancer Progression. DNA and Cell Biology, 43(12), 605-618. https://doi.org/10.1089/dna.2024.0122
Vancouver
Huang C, Xue L, Lin X, Shen Y, Wang X. Histone Lactylation-Driven GPD2 Mediates M2 Macrophage Polarization to Promote Malignant Transformation of Cervical Cancer Progression. DNA and Cell Biology. 2024;43(12):605-618. doi:10.1089/dna.2024.0122
BibTeX
@article{Huang2024,
author = {Huang, Chenlingzi and Xue, Lujiadai and Lin, Xinzi and Shen, Yuan and Wang, Xiaoyu},
title = {Histone Lactylation-Driven GPD2 Mediates M2 Macrophage Polarization to Promote Malignant Transformation of Cervical Cancer Progression},
journal = {DNA and Cell Biology},
year = {2024},
volume = {43},
number = {12},
pages = {605--618},
doi = {10.1089/dna.2024.0122}
}
EUVIMED